Literature DB >> 9201905

Structural study of the relationship between the rate of membrane fusion and the ability of the fusion peptide of influenza virus to perturb bilayers.

A Colotto1, R M Epand.   

Abstract

The amino-terminal segment of the HA2 protein of influenza virus (fusion peptide) has been identified as an important region for membrane fusion. The wild type virus can fuse to membranes more rapidly at pH 5 than at pH 7.4. It has been demonstrated that there is a relationship between the ability of the peptide to promote the formation of inverted phases and the fusogenicity of the intact virus. In this work, we use small-angle X-ray diffraction to study the mechanism of the structural effect of the peptide, at different pHs, on lipid systems characterized by each having a different spontaneous radius of curvature. The overall results show that the action of the peptide on the polymorphism of the lipid systems investigated is strongly pH-dependent. In particular, a rapid formation of cubic phases at pH 5.0 is observed in the presence of this fusion peptide. The ability of the fusion peptide to promote cubic phases exhibits the same dependence on the pH as does the fusogenicity of the intact virus. It is proposed that the peptide promotes cubic phases at pH 5.0 by changing the kinetics of the lamellar to inverted phase transitions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9201905     DOI: 10.1021/bi970382u

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  27 in total

1.  Implicit solvent model studies of the interactions of the influenza hemagglutinin fusion peptide with lipid bilayers.

Authors:  D Bechor; N Ben-Tal
Journal:  Biophys J       Date:  2001-02       Impact factor: 4.033

2.  Ultrastructural characterization of peptide-induced membrane fusion and peptide self-assembly in the lipid bilayer.

Authors:  A S Ulrich; W Tichelaar; G Förster; O Zschörnig; S Weinkauf; H W Meyer
Journal:  Biophys J       Date:  1999-08       Impact factor: 4.033

3.  Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion.

Authors:  T Suárez; W R Gallaher; A Agirre; F M Goñi; J L Nieva
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Membrane permeability changes at early stages of influenza hemagglutinin-mediated fusion.

Authors:  V A Frolov; A Y Dunina-Barkovskaya; A V Samsonov; J Zimmerberg
Journal:  Biophys J       Date:  2003-09       Impact factor: 4.033

5.  The modified stalk mechanism of lamellar/inverted phase transitions and its implications for membrane fusion.

Authors:  D P Siegel
Journal:  Biophys J       Date:  1999-01       Impact factor: 4.033

6.  15N NMR study of the ionization properties of the influenza virus fusion peptide in zwitterionic phospholipid dispersions.

Authors:  Z Zhou; J C Macosko; D W Hughes; B G Sayer; J Hawes; R M Epand
Journal:  Biophys J       Date:  2000-05       Impact factor: 4.033

7.  Bilayer conformation of fusion peptide of influenza virus hemagglutinin: a molecular dynamics simulation study.

Authors:  Qiang Huang; Cheng-Lung Chen; Andreas Herrmann
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

8.  Viral fusion protein transmembrane domain adopts β-strand structure to facilitate membrane topological changes for virus-cell fusion.

Authors:  Hongwei Yao; Michelle W Lee; Alan J Waring; Gerard C L Wong; Mei Hong
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

9.  Fusion peptides promote formation of bilayer cubic phases in lipid dispersions. An x-ray diffraction study.

Authors:  Boris G Tenchov; Robert C MacDonald; Barry R Lentz
Journal:  Biophys J       Date:  2013-03-05       Impact factor: 4.033

10.  Nuclear magnetic resonance evidence for retention of a lamellar membrane phase with curvature in the presence of large quantities of the HIV fusion peptide.

Authors:  Charles M Gabrys; Rong Yang; Christopher M Wasniewski; Jun Yang; Christian G Canlas; Wei Qiang; Yan Sun; David P Weliky
Journal:  Biochim Biophys Acta       Date:  2009-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.